MORGAN STANLEY - EUCRATES BIOMEDICAL ACQU COR ownership

Back to all holdings Add to watchlist

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 40 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$39,0000.0%3,9000.0%0.00%–
Q2 2022$39,000
+2.6%
3,9000.0%0.00%–
Q1 2022$38,0000.0%3,9000.0%0.00%–
Q4 2021$38,0000.0%3,9000.0%0.00%–
Q3 2021$38,0000.0%3,9000.0%0.00%–
Q2 2021$38,000–3,900–0.00%–
 Download
Other shareholders

There were no reported owners of EUCRATES BIOMEDICAL ACQU COR in Q1 2022.

NameSharesValueWeighting ↓
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders